INCANNEX HEALTHCARE LIMITED - Announcements

0.00%

4.1¢

Currently unlisted.

Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical... Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease. Its drug candidates include IHL-42X, IHL-216A and HL-675A. Its IHL-42X is a combination of acetazolamide and dronabinol for treatment of OSA. Its IHL-216A is a combination of isoflurane and cannabidiol (CBD) to prevent development of TBI/concussion. Its HL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. It is also investigating the use of psilocybin assisted psychotherapy to treat GAD.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

IHL	Positive FDA Pre-IND meeting guides IHL-675A development	PRICE SENSITIVE	22/04/21	186.96KB	Share
IHL	IHL-675A Pre-IND meeting with FDA update	PRICE SENSITIVE	25/03/21	153.84KB	Share
IHL	IHL-675A outperforms existing treatment for arthritis	PRICE SENSITIVE	16/03/21	499.43KB	Share
IHL	Trading Halt	PRICE SENSITIVE	12/03/21	205.55KB	Share
IHL	IHL-216A to be assessed in NFL model of concussion	PRICE SENSITIVE	11/03/21	185.15KB	Share
IHL	Appendix 4D correction	PRICE SENSITIVE	26/02/21	141.19KB	Share
IHL	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.03MB	Share
IHL	IHL-675A in vivo results for Inflammatory Bowel Disease	PRICE SENSITIVE	16/02/21	384.42KB	Share
IHL	Trading Halt	PRICE SENSITIVE	12/02/21	201.85KB	Share
IHL	IHL appoints EAS Advisors LLC to facilitate US listing	PRICE SENSITIVE	11/02/21	152.34KB	Share
IHL	IHL-675A in vivo results for COPD and asthma	PRICE SENSITIVE	04/02/21	290.02KB	Share
IHL	Quarterly Activities Report - Dec 2020	PRICE SENSITIVE	29/01/21	439.5KB	Share
IHL	Incannex AGM Presentation	PRICE SENSITIVE	25/01/21	2.66MB	Share
IHL	First patients recruited for IHL-42X (OSA) trial	PRICE SENSITIVE	21/12/20	162.33KB	Share
IHL	Positive results from IHL-216A TBI/concussion study	PRICE SENSITIVE	15/12/20	453.78KB	Share
IHL	IHL initiates psilocybin clinical trial for anxiety disorder	PRICE SENSITIVE	08/12/20	1.25MB	Share
IHL	Trading Halt	PRICE SENSITIVE	04/12/20	202.56KB	Share
IHL	Positive IHL-675A in vivo results and FDA Pathway	PRICE SENSITIVE	23/11/20	439.93KB	Share
IHL	Trading Halt	PRICE SENSITIVE	19/11/20	204.17KB	Share
IHL	Strong anti-inflammatory action from IHL-675A	PRICE SENSITIVE	05/11/20	355.62KB	Share
IHL	Trading Halt	PRICE SENSITIVE	03/11/20	206.62KB	Share
IHL	Trading Halt	PRICE SENSITIVE	03/11/20	206.63KB	Share
IHL	Sep20 Quarterly Activities update and Appendix 4C	PRICE SENSITIVE	22/10/20	439.62KB	Share
IHL	Record Sales for September Quarter	PRICE SENSITIVE	06/10/20	184.21KB	Share
IHL	Completion of IHLOB Exercise Program (incl. Appendix 2As)	PRICE SENSITIVE	02/10/20	284.17KB	Share
IHL	IHL Receives Ethics Approval for Phase 2 OSA Trial	PRICE SENSITIVE	24/09/20	159.67KB	Share
IHL	Positive Results from IHL-675A (ARDS) in vitro Study	PRICE SENSITIVE	26/08/20	301.35KB	Share
IHL	Preliminary Final Report	PRICE SENSITIVE	14/08/20	1.46MB	Share
IHL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/07/20	438.36KB	Share
IHL	IHL commences IHL-216A TBI / Concussion Animal Study	PRICE SENSITIVE	23/07/20	153.78KB	Share
IHL	Positive Results from IHL-675 (ARDS) animal study	PRICE SENSITIVE	17/07/20	317.91KB	Share
IHL	Trading Halt	PRICE SENSITIVE	15/07/20	206.94KB	Share
IHL	Clinical Update on IHL-42X for Obstructive Sleep Apnoea	PRICE SENSITIVE	09/07/20	232.27KB	Share
IHL	Record Sales for June Quarter	PRICE SENSITIVE	02/07/20	177.63KB	Share
IHL	Oral Devices and Cannabinoid Sales Update	PRICE SENSITIVE	03/06/20	155.58KB	Share
IHL	IHL commences IHL-675 (ARDS) animal study	PRICE SENSITIVE	02/06/20	171.21KB	Share
IHL	NRL player James Graham joins Impression TBI program	PRICE SENSITIVE	19/05/20	155.07KB	Share
IHL	Resubmission Appendix 4C - ASX new format	PRICE SENSITIVE	15/05/20	295.96KB	Share
IHL	Quarterly Update and Appendix 4C	PRICE SENSITIVE	30/04/20	369.66KB	Share
IHL	IHL-675A Hydroxychloroquine and CBD for ARDS	PRICE SENSITIVE	15/04/20	242.54KB	Share
IHL	IHL-42x (OSA) accelerated FDA approval pathway	PRICE SENSITIVE	25/03/20	2.36MB	Share
IHL	IHL Acquires CBD Inhalers for Lung Inflammation	PRICE SENSITIVE	19/03/20	166.94KB	Share
IHL	Trading Halt	PRICE SENSITIVE	17/03/20	533.18KB	Share
IHL	Clinical Progress on IHL-216A for TBI and CTE	PRICE SENSITIVE	03/03/20	207.75KB	Share
IHL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	28/02/20	749.43KB	Share
IHL	Expansion-IncannexTM Cannabinoid Oil Sales Prog/Option Ex.	PRICE SENSITIVE	13/02/20	227.36KB	Share
IHL	RESUBMISSION - Quarterly Update and Appendix 4C	PRICE SENSITIVE	31/01/20	355.53KB	Share
IHL	Quarterly Activities Update and Appendix 4C	PRICE SENSITIVE	31/01/20	355.37KB	Share
IHL	Clinical Progress on IHL-42X for Obstructive Sleep Apnoea	PRICE SENSITIVE	29/01/20	172.54KB	Share
IHL	IHL Files Patent over IHL-42X for OSA	PRICE SENSITIVE	06/12/19	147.98KB	Share
IHL	IHL appoints Big-Pharma expert to lead drug development	PRICE SENSITIVE	04/11/19	241.17KB	Share
IHL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	01/11/19	361.79KB	Share
IHL	Cleansing Prospectus	PRICE SENSITIVE	24/10/19	400.07KB	Share
IHL	IHL completes $5m capital raise	PRICE SENSITIVE	24/10/19	170.93KB	Share
IHL	Trading Halt	PRICE SENSITIVE	22/10/19	349.14KB	Share
IHL	Incannex Presentation - Dr Sud Agarwal - CMO	PRICE SENSITIVE	04/10/19	6.91MB	Share
IHL	IHL files cannabinoid patent over IHL-216A for TBI	PRICE SENSITIVE	04/10/19	187.09KB	Share
IHL	Incannex CBD Oils and Medical Advisory Appointees	PRICE SENSITIVE	05/09/19	184.01KB	Share
IHL	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	30/08/19	1.96MB	Share
IHL	Major supply agreement - Air Liquide Healthcare	PRICE SENSITIVE	27/08/19	182.53KB	Share
IHL	Commencement of Phase 2a Sleep Apnoea Clinical Trial	PRICE SENSITIVE	13/08/19	179.17KB	Share
IHL	Reinstatement to Official Quotation	PRICE SENSITIVE	09/08/19	212.34KB	Share
IHL	Oil Supply Agreement and Brand Launch	PRICE SENSITIVE	09/08/19	282.73KB	Share
IHL	Voluntary Suspension from Official Quotation	PRICE SENSITIVE	08/08/19	349.28KB	Share
IHL	Trading Halt	PRICE SENSITIVE	06/08/19	436.67KB	Share
IHL	Official Supplier and Research Partner - ONE Championship	PRICE SENSITIVE	02/08/19	194.6KB	Share
IHL	Quarterly update and Cashflow Report	PRICE SENSITIVE	31/07/19	370.7KB	Share
IHL	Dr Sud Agarwal appointed as CMO & Non-Executive Director	PRICE SENSITIVE	25/07/19	157.71KB	Share
IHL	Concussion Monitoring FiTGuard - Major Territory Expansion	PRICE SENSITIVE	17/07/19	537.67KB	Share
IHL	Response to ASX Price Query	PRICE SENSITIVE	15/07/19	405.44KB	Share
IHL	Cleansing Prospectus	PRICE SENSITIVE	09/07/19	221.04KB	Share
IHL	Dronabinol Supply Agreement/Sleep Apnoea Trial Update	PRICE SENSITIVE	05/07/19	193.44KB	Share
IHL	Successful $1.65m Placement/International Expansion	PRICE SENSITIVE	03/07/19	213.99KB	Share
IHL	Trading Halt	PRICE SENSITIVE	01/07/19	337.21KB	Share
IHL	Concussion research partner and supplier to Boxing Australia	PRICE SENSITIVE	28/06/19	209.76KB	Share
IHL	Commencement of Phase 2a Periodontitis Clinical Trial	PRICE SENSITIVE	24/06/19	207.63KB	Share
IHL	Exclusive Concussion Monitoring FitGuard Supply Agreement	PRICE SENSITIVE	06/06/19	770.72KB	Share
IHL	CBD Supply Agreement - Clinical trial Iminent	PRICE SENSITIVE	03/06/19	196.45KB	Share
IHL	Trading Halt	PRICE SENSITIVE	30/05/19	203.91KB	Share
IHL	Pause in Trading	PRICE SENSITIVE	30/05/19	116.99KB	Share
IHL	Reinstatement to Official Quotation	PRICE SENSITIVE	21/05/19	212.57KB	Share
IHL	Company Update - Federal Court Orders	PRICE SENSITIVE	21/05/19	1.61MB	Share
IHL	Company Update - Lodgement of Cleansing Prospectus	PRICE SENSITIVE	10/05/19	162.58KB	Share
IHL	Cleansing Prospectus	PRICE SENSITIVE	10/05/19	599.87KB	Share
IHL	Voluntary Suspenion from Official Quotation	PRICE SENSITIVE	08/05/19	385.07KB	Share
IHL	Trading Halt	PRICE SENSITIVE	06/05/19	354.37KB	Share
IHL	Quarterly activities report and cashflow	PRICE SENSITIVE	30/04/19	366.36KB	Share
IHL	Major Distribution Agreement	PRICE SENSITIVE	21/03/19	277.52KB	Share
IHL	Trading Halt	PRICE SENSITIVE	19/03/19	335.64KB	Share
IHL	Half Year Results	PRICE SENSITIVE	27/02/19	891.26KB	Share
IHL	Dronabinol Agreement with RespireRx	PRICE SENSITIVE	15/02/19	287.88KB	Share
IHL	Quarterly activities report and Appendix 4C	PRICE SENSITIVE	31/01/19	336.84KB	Share
IHL	Supply Agreement with 1300 Smiles	PRICE SENSITIVE	23/01/19	205.58KB	Share
IHL	Receipt of Medicinal Cannabis Licenses	PRICE SENSITIVE	16/01/19	199.59KB	Share
IHL	MoU for the Exclusive Sales and Distribution of FiTGuard	PRICE SENSITIVE	11/01/19	213.63KB	Share
IHL	MOU for Cannabis Oils from Canadian Producer	PRICE SENSITIVE	19/12/18	156.12KB	Share
IHL	Lodgement of Medicinal Cannabis License Application	PRICE SENSITIVE	12/12/18	153.72KB	Share
IHL	Expansion of Oral Devices into China and Asia	PRICE SENSITIVE	11/12/18	219.05KB	Share
IHL	Exclusive Agreement for Commercialisation of Dronabinol	PRICE SENSITIVE	04/12/18	178.05KB	Share
IHL	Quarterly Update and Appendix 4C	PRICE SENSITIVE	30/10/18	373.75KB	Share

IHL Positive FDA Pre-IND meeting guides IHL-675A development
22/04/21	PRICE SENSITIVE	186.96KB	Share
IHL IHL-675A Pre-IND meeting with FDA update
25/03/21	PRICE SENSITIVE	153.84KB	Share
IHL IHL-675A outperforms existing treatment for arthritis
16/03/21	PRICE SENSITIVE	499.43KB	Share
IHL Trading Halt
12/03/21	PRICE SENSITIVE	205.55KB	Share
IHL IHL-216A to be assessed in NFL model of concussion
11/03/21	PRICE SENSITIVE	185.15KB	Share
IHL Appendix 4D correction
26/02/21	PRICE SENSITIVE	141.19KB	Share
IHL Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.03MB	Share
IHL IHL-675A in vivo results for Inflammatory Bowel Disease
16/02/21	PRICE SENSITIVE	384.42KB	Share
IHL Trading Halt
12/02/21	PRICE SENSITIVE	201.85KB	Share
IHL IHL appoints EAS Advisors LLC to facilitate US listing
11/02/21	PRICE SENSITIVE	152.34KB	Share
IHL IHL-675A in vivo results for COPD and asthma
04/02/21	PRICE SENSITIVE	290.02KB	Share
IHL Quarterly Activities Report - Dec 2020
29/01/21	PRICE SENSITIVE	439.5KB	Share
IHL Incannex AGM Presentation
25/01/21	PRICE SENSITIVE	2.66MB	Share
IHL First patients recruited for IHL-42X (OSA) trial
21/12/20	PRICE SENSITIVE	162.33KB	Share
IHL Positive results from IHL-216A TBI/concussion study
15/12/20	PRICE SENSITIVE	453.78KB	Share
IHL IHL initiates psilocybin clinical trial for anxiety disorder
08/12/20	PRICE SENSITIVE	1.25MB	Share
IHL Trading Halt
04/12/20	PRICE SENSITIVE	202.56KB	Share
IHL Positive IHL-675A in vivo results and FDA Pathway
23/11/20	PRICE SENSITIVE	439.93KB	Share
IHL Trading Halt
19/11/20	PRICE SENSITIVE	204.17KB	Share
IHL Strong anti-inflammatory action from IHL-675A
05/11/20	PRICE SENSITIVE	355.62KB	Share
IHL Trading Halt
03/11/20	PRICE SENSITIVE	206.62KB	Share
IHL Trading Halt
03/11/20	PRICE SENSITIVE	206.63KB	Share
IHL Sep20 Quarterly Activities update and Appendix 4C
22/10/20	PRICE SENSITIVE	439.62KB	Share
IHL Record Sales for September Quarter
06/10/20	PRICE SENSITIVE	184.21KB	Share
IHL Completion of IHLOB Exercise Program (incl. Appendix 2As)
02/10/20	PRICE SENSITIVE	284.17KB	Share
IHL IHL Receives Ethics Approval for Phase 2 OSA Trial
24/09/20	PRICE SENSITIVE	159.67KB	Share
IHL Positive Results from IHL-675A (ARDS) in vitro Study
26/08/20	PRICE SENSITIVE	301.35KB	Share
IHL Preliminary Final Report
14/08/20	PRICE SENSITIVE	1.46MB	Share
IHL Quarterly Activities Report and Appendix 4C
29/07/20	PRICE SENSITIVE	438.36KB	Share
IHL IHL commences IHL-216A TBI / Concussion Animal Study
23/07/20	PRICE SENSITIVE	153.78KB	Share
IHL Positive Results from IHL-675 (ARDS) animal study
17/07/20	PRICE SENSITIVE	317.91KB	Share
IHL Trading Halt
15/07/20	PRICE SENSITIVE	206.94KB	Share
IHL Clinical Update on IHL-42X for Obstructive Sleep Apnoea
09/07/20	PRICE SENSITIVE	232.27KB	Share
IHL Record Sales for June Quarter
02/07/20	PRICE SENSITIVE	177.63KB	Share
IHL Oral Devices and Cannabinoid Sales Update
03/06/20	PRICE SENSITIVE	155.58KB	Share
IHL IHL commences IHL-675 (ARDS) animal study
02/06/20	PRICE SENSITIVE	171.21KB	Share
IHL NRL player James Graham joins Impression TBI program
19/05/20	PRICE SENSITIVE	155.07KB	Share
IHL Resubmission Appendix 4C - ASX new format
15/05/20	PRICE SENSITIVE	295.96KB	Share
IHL Quarterly Update and Appendix 4C
30/04/20	PRICE SENSITIVE	369.66KB	Share
IHL IHL-675A Hydroxychloroquine and CBD for ARDS
15/04/20	PRICE SENSITIVE	242.54KB	Share
IHL IHL-42x (OSA) accelerated FDA approval pathway
25/03/20	PRICE SENSITIVE	2.36MB	Share
IHL IHL Acquires CBD Inhalers for Lung Inflammation
19/03/20	PRICE SENSITIVE	166.94KB	Share
IHL Trading Halt
17/03/20	PRICE SENSITIVE	533.18KB	Share
IHL Clinical Progress on IHL-216A for TBI and CTE
03/03/20	PRICE SENSITIVE	207.75KB	Share
IHL Appendix 4D and Half Year Accounts
28/02/20	PRICE SENSITIVE	749.43KB	Share
IHL Expansion-IncannexTM Cannabinoid Oil Sales Prog/Option Ex.
13/02/20	PRICE SENSITIVE	227.36KB	Share
IHL RESUBMISSION - Quarterly Update and Appendix 4C
31/01/20	PRICE SENSITIVE	355.53KB	Share
IHL Quarterly Activities Update and Appendix 4C
31/01/20	PRICE SENSITIVE	355.37KB	Share
IHL Clinical Progress on IHL-42X for Obstructive Sleep Apnoea
29/01/20	PRICE SENSITIVE	172.54KB	Share
IHL IHL Files Patent over IHL-42X for OSA
06/12/19	PRICE SENSITIVE	147.98KB	Share
IHL IHL appoints Big-Pharma expert to lead drug development
04/11/19	PRICE SENSITIVE	241.17KB	Share
IHL Quarterly Activities Report and Appendix 4C
01/11/19	PRICE SENSITIVE	361.79KB	Share
IHL Cleansing Prospectus
24/10/19	PRICE SENSITIVE	400.07KB	Share
IHL IHL completes $5m capital raise
24/10/19	PRICE SENSITIVE	170.93KB	Share
IHL Trading Halt
22/10/19	PRICE SENSITIVE	349.14KB	Share
IHL Incannex Presentation - Dr Sud Agarwal - CMO
04/10/19	PRICE SENSITIVE	6.91MB	Share
IHL IHL files cannabinoid patent over IHL-216A for TBI
04/10/19	PRICE SENSITIVE	187.09KB	Share
IHL Incannex CBD Oils and Medical Advisory Appointees
05/09/19	PRICE SENSITIVE	184.01KB	Share
IHL Preliminary Final Report - Appendix 4E
30/08/19	PRICE SENSITIVE	1.96MB	Share
IHL Major supply agreement - Air Liquide Healthcare
27/08/19	PRICE SENSITIVE	182.53KB	Share
IHL Commencement of Phase 2a Sleep Apnoea Clinical Trial
13/08/19	PRICE SENSITIVE	179.17KB	Share
IHL Reinstatement to Official Quotation
09/08/19	PRICE SENSITIVE	212.34KB	Share
IHL Oil Supply Agreement and Brand Launch
09/08/19	PRICE SENSITIVE	282.73KB	Share
IHL Voluntary Suspension from Official Quotation
08/08/19	PRICE SENSITIVE	349.28KB	Share
IHL Trading Halt
06/08/19	PRICE SENSITIVE	436.67KB	Share
IHL Official Supplier and Research Partner - ONE Championship
02/08/19	PRICE SENSITIVE	194.6KB	Share
IHL Quarterly update and Cashflow Report
31/07/19	PRICE SENSITIVE	370.7KB	Share
IHL Dr Sud Agarwal appointed as CMO & Non-Executive Director
25/07/19	PRICE SENSITIVE	157.71KB	Share
IHL Concussion Monitoring FiTGuard - Major Territory Expansion
17/07/19	PRICE SENSITIVE	537.67KB	Share
IHL Response to ASX Price Query
15/07/19	PRICE SENSITIVE	405.44KB	Share
IHL Cleansing Prospectus
09/07/19	PRICE SENSITIVE	221.04KB	Share
IHL Dronabinol Supply Agreement/Sleep Apnoea Trial Update
05/07/19	PRICE SENSITIVE	193.44KB	Share
IHL Successful $1.65m Placement/International Expansion
03/07/19	PRICE SENSITIVE	213.99KB	Share
IHL Trading Halt
01/07/19	PRICE SENSITIVE	337.21KB	Share
IHL Concussion research partner and supplier to Boxing Australia
28/06/19	PRICE SENSITIVE	209.76KB	Share
IHL Commencement of Phase 2a Periodontitis Clinical Trial
24/06/19	PRICE SENSITIVE	207.63KB	Share
IHL Exclusive Concussion Monitoring FitGuard Supply Agreement
06/06/19	PRICE SENSITIVE	770.72KB	Share
IHL CBD Supply Agreement - Clinical trial Iminent
03/06/19	PRICE SENSITIVE	196.45KB	Share
IHL Trading Halt
30/05/19	PRICE SENSITIVE	203.91KB	Share
IHL Pause in Trading
30/05/19	PRICE SENSITIVE	116.99KB	Share
IHL Reinstatement to Official Quotation
21/05/19	PRICE SENSITIVE	212.57KB	Share
IHL Company Update - Federal Court Orders
21/05/19	PRICE SENSITIVE	1.61MB	Share
IHL Company Update - Lodgement of Cleansing Prospectus
10/05/19	PRICE SENSITIVE	162.58KB	Share
IHL Cleansing Prospectus
10/05/19	PRICE SENSITIVE	599.87KB	Share
IHL Voluntary Suspenion from Official Quotation
08/05/19	PRICE SENSITIVE	385.07KB	Share
IHL Trading Halt
06/05/19	PRICE SENSITIVE	354.37KB	Share
IHL Quarterly activities report and cashflow
30/04/19	PRICE SENSITIVE	366.36KB	Share
IHL Major Distribution Agreement
21/03/19	PRICE SENSITIVE	277.52KB	Share
IHL Trading Halt
19/03/19	PRICE SENSITIVE	335.64KB	Share
IHL Half Year Results
27/02/19	PRICE SENSITIVE	891.26KB	Share
IHL Dronabinol Agreement with RespireRx
15/02/19	PRICE SENSITIVE	287.88KB	Share
IHL Quarterly activities report and Appendix 4C
31/01/19	PRICE SENSITIVE	336.84KB	Share
IHL Supply Agreement with 1300 Smiles
23/01/19	PRICE SENSITIVE	205.58KB	Share
IHL Receipt of Medicinal Cannabis Licenses
16/01/19	PRICE SENSITIVE	199.59KB	Share
IHL MoU for the Exclusive Sales and Distribution of FiTGuard
11/01/19	PRICE SENSITIVE	213.63KB	Share
IHL MOU for Cannabis Oils from Canadian Producer
19/12/18	PRICE SENSITIVE	156.12KB	Share
IHL Lodgement of Medicinal Cannabis License Application
12/12/18	PRICE SENSITIVE	153.72KB	Share
IHL Expansion of Oral Devices into China and Asia
11/12/18	PRICE SENSITIVE	219.05KB	Share
IHL Exclusive Agreement for Commercialisation of Dronabinol
04/12/18	PRICE SENSITIVE	178.05KB	Share
IHL Quarterly Update and Appendix 4C
30/10/18	PRICE SENSITIVE	373.75KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

INCANNEX HEALTHCARE LIMITED - Announcements

Announcements

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories